chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Fatigue, Illness, Malaise, Pain, Pyrexia
Clinical narrative: Sick; Aches; Not feeling well; Tired/Fatigue; Fever; This spontaneous case was reported by a physician and describes the occurrence of ILLNESS (Sick), PAIN (Aches), MALAISE (Not feeling well), FATIGUE (Tired/Fatigue) and PYREXIA (Fever) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick), PAIN (Aches), MALAISE (Not feeling well), FATIGUE (Tired/Fatigue) and PYREXIA (Fever). At the time of the report, ILLNESS (Sick), PAIN (Aches), MALAISE (Not feeling well), FATIGUE (Tired/Fatigue) and PYREXIA (Fever) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Dyspnoea, Epistaxis, Fatigue, Fear
Clinical narrative: Got really disoriented; Nose was gushing blood for an hour and half; Felt horrible and horrific; Couldn't breath; Nose was blocked; Felt ill for 2weeks,Feels like she's not right till today; Will not receive second dose; Headache; Fatigue,extremly tired; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Got really disoriented), EPISTAXIS (Nose was gushing blood for an hour and half), FEAR (Felt horrible and horrific), DYSPNOEA (Couldn't breath) and NASAL CONGESTION (Nose was blocked) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISORIENTATION (Got really disoriented), EPISTAXIS (Nose was gushing blood for an hour and half), FEAR (Felt horrible and horrific), DYSPNOEA (Couldn't breath), NASAL CONGESTION (Nose was blocked), ILLNESS (Felt ill for 2weeks,Feels like she's not right till today), PRODUCT DOSE OMISSION ISSUE (Will not receive second dose), HEADACHE (Headache), FATIGUE (Fatigue,extremly tired) and MYALGIA (Muscle pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DISORIENTATION (Got really disoriented), EPISTAXIS (Nose was gushing blood for an hour and half), FEAR (Felt horrible and horrific), DYSPNOEA (Couldn't breath), NASAL CONGESTION (Nose was blocked), ILLNESS (Felt ill for 2weeks,Feels like she's not right till today), PRODUCT DOSE OMISSION ISSUE (Will not receive second dose), HEADACHE (Headache), FATIGUE (Fatigue,extremly tired) and MYALGIA (Muscle pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Myalgia, Nasal congestion, Product dose omission issue
Clinical narrative: Got really disoriented; Nose was gushing blood for an hour and half; Felt horrible and horrific; Couldn't breath; Nose was blocked; Felt ill for 2weeks,Feels like she's not right till today; Will not receive second dose; Headache; Fatigue,extremly tired; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Got really disoriented), EPISTAXIS (Nose was gushing blood for an hour and half), FEAR (Felt horrible and horrific), DYSPNOEA (Couldn't breath) and NASAL CONGESTION (Nose was blocked) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DISORIENTATION (Got really disoriented), EPISTAXIS (Nose was gushing blood for an hour and half), FEAR (Felt horrible and horrific), DYSPNOEA (Couldn't breath), NASAL CONGESTION (Nose was blocked), ILLNESS (Felt ill for 2weeks,Feels like she's not right till today), PRODUCT DOSE OMISSION ISSUE (Will not receive second dose), HEADACHE (Headache), FATIGUE (Fatigue,extremly tired) and MYALGIA (Muscle pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DISORIENTATION (Got really disoriented), EPISTAXIS (Nose was gushing blood for an hour and half), FEAR (Felt horrible and horrific), DYSPNOEA (Couldn't breath), NASAL CONGESTION (Nose was blocked), ILLNESS (Felt ill for 2weeks,Feels like she's not right till today), PRODUCT DOSE OMISSION ISSUE (Will not receive second dose), HEADACHE (Headache), FATIGUE (Fatigue,extremly tired) and MYALGIA (Muscle pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications reported.
Sex: M
Vaccine: COVID19
Symptoms: Eye operation, Inappropriate schedule of product administration
Clinical narrative: Eye surgery after first dose; inappropriate schedule of vaccination; This spontaneous case was reported by a consumer and describes the occurrence of EYE OPERATION (Eye surgery after first dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE OPERATION (Eye surgery after first dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccination). At the time of the report, EYE OPERATION (Eye surgery after first dose) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided. Patient had one shot of the Moderna and was told not to get the second one the day before eye surgery.  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Balance disorder, Chills, Dizziness
Clinical narrative: Loss of balance; dizziness; vision problem; Aches in neck; weakness; headache; Chills; Aches in joints; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), VISUAL IMPAIRMENT (vision problem), NECK PAIN (Aches in neck) and ASTHENIA (weakness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), VISUAL IMPAIRMENT (vision problem), NECK PAIN (Aches in neck), ASTHENIA (weakness), HEADACHE (headache), CHILLS (Chills) and ARTHRALGIA (Aches in joints). At the time of the report, BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), NECK PAIN (Aches in neck), CHILLS (Chills) and ARTHRALGIA (Aches in joints) had resolved and VISUAL IMPAIRMENT (vision problem), ASTHENIA (weakness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-Jul-2021 contains Significant informations
Sex: U
Vaccine: COVID19
Symptoms: Headache, Neck pain, Visual impairment
Clinical narrative: Loss of balance; dizziness; vision problem; Aches in neck; weakness; headache; Chills; Aches in joints; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), VISUAL IMPAIRMENT (vision problem), NECK PAIN (Aches in neck) and ASTHENIA (weakness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), VISUAL IMPAIRMENT (vision problem), NECK PAIN (Aches in neck), ASTHENIA (weakness), HEADACHE (headache), CHILLS (Chills) and ARTHRALGIA (Aches in joints). At the time of the report, BALANCE DISORDER (Loss of balance), DIZZINESS (dizziness), NECK PAIN (Aches in neck), CHILLS (Chills) and ARTHRALGIA (Aches in joints) had resolved and VISUAL IMPAIRMENT (vision problem), ASTHENIA (weakness) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-Jul-2021 contains Significant informations
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: I have a rash on my left back side about 6 inches from the vaccine shot location; This spontaneous case was reported by a consumer and describes the occurrence of RASH (I have a rash on my left back side about 6 inches from the vaccine shot location) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (I have a rash on my left back side about 6 inches from the vaccine shot location). At the time of the report, RASH (I have a rash on my left back side about 6 inches from the vaccine shot location) outcome was unknown.            No relevant concomitant medications were reported. No treatment medications provided by the reporter.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Condition aggravated, Insomnia, Paraesthesia
Clinical narrative: Tingling getting worse and more often; Tingling getting worse and more often; Tough time sleeping; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling getting worse and more often), CONDITION AGGRAVATED (Tingling getting worse and more often) and INSOMNIA (Tough time sleeping) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling getting worse and more often), CONDITION AGGRAVATED (Tingling getting worse and more often) and INSOMNIA (Tough time sleeping). At the time of the report, PARAESTHESIA (Tingling getting worse and more often), CONDITION AGGRAVATED (Tingling getting worse and more often) and INSOMNIA (Tough time sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Not feeling good; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling good) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling good). At the time of the report, MALAISE (Not feeling good) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. Treatment information was not provided. Concomitant product use was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Hyperhidrosis
Clinical narrative: sweating to death; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating to death) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweating to death). At the time of the report, HYPERHIDROSIS (sweating to death) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow up received and contains dose 2 information and action taken updated. Event (missed dose) deleted.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: common side effects; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Jun-2021 and was forwarded to Moderna on 04-Jun-2021.    This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Jun-2021 and was forwarded to Moderna on 06-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (common side effects) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Elevated blood pressure reading without diagnosis of hypertension. Concomitant products included AMLODIPINE for an unknown indication.    On 04-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced ADVERSE REACTION (common side effects). At the time of the report, ADVERSE REACTION (common side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medication was reported.  Treatment medications were unknown. The action taken with mRNA-1273 in response to the event was not applicable.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Gastrooesophageal reflux disease, Insomnia, Pain in extremity
Clinical narrative: Can't sleep at night; Anxiety; Acid Reflux; 2nd Dose Missed; Feeling tired; Tight feeling in her throat like someone is chocking,Pressure on throat; Arm was little sore; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Jun-2021 and was forwarded to Moderna on 08-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Tight feeling in her throat like someone is chocking,Pressure on throat), PAIN IN EXTREMITY (Arm was little sore), INSOMNIA (Can't sleep at night), ANXIETY (Anxiety) and GASTROOESOPHAGEAL REFLUX DISEASE (Acid Reflux) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm was little sore). On an unknown date, the patient experienced THROAT TIGHTNESS (Tight feeling in her throat like someone is chocking,Pressure on throat), INSOMNIA (Can't sleep at night), ANXIETY (Anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (Acid Reflux), PRODUCT DOSE OMISSION ISSUE (2nd Dose Missed) and FATIGUE (Feeling tired). The patient was treated with OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) at a dose of UNK dosage form. At the time of the report, THROAT TIGHTNESS (Tight feeling in her throat like someone is chocking,Pressure on throat), PAIN IN EXTREMITY (Arm was little sore), INSOMNIA (Can't sleep at night), ANXIETY (Anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (Acid Reflux), PRODUCT DOSE OMISSION ISSUE (2nd Dose Missed) and FATIGUE (Feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Throat tightness
Clinical narrative: Can't sleep at night; Anxiety; Acid Reflux; 2nd Dose Missed; Feeling tired; Tight feeling in her throat like someone is chocking,Pressure on throat; Arm was little sore; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Jun-2021 and was forwarded to Moderna on 08-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Tight feeling in her throat like someone is chocking,Pressure on throat), PAIN IN EXTREMITY (Arm was little sore), INSOMNIA (Can't sleep at night), ANXIETY (Anxiety) and GASTROOESOPHAGEAL REFLUX DISEASE (Acid Reflux) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm was little sore). On an unknown date, the patient experienced THROAT TIGHTNESS (Tight feeling in her throat like someone is chocking,Pressure on throat), INSOMNIA (Can't sleep at night), ANXIETY (Anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (Acid Reflux), PRODUCT DOSE OMISSION ISSUE (2nd Dose Missed) and FATIGUE (Feeling tired). The patient was treated with OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) at a dose of UNK dosage form. At the time of the report, THROAT TIGHTNESS (Tight feeling in her throat like someone is chocking,Pressure on throat), PAIN IN EXTREMITY (Arm was little sore), INSOMNIA (Can't sleep at night), ANXIETY (Anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (Acid Reflux), PRODUCT DOSE OMISSION ISSUE (2nd Dose Missed) and FATIGUE (Feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: received the Moderna COVID-19 Vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (received the Moderna COVID-19 Vaccine while pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (received the Moderna COVID-19 Vaccine while pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (received the Moderna COVID-19 Vaccine while pregnant) had resolved.            Concomitant medications were not provided. Treatment information was not reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Pain
Clinical narrative: body aches; dizziness; mild headache; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), DIZZINESS (dizziness), HEADACHE (mild headache), FATIGUE (fatigue) and CHILLS (chills) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), DIZZINESS (dizziness), HEADACHE (mild headache), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, PAIN (body aches), DIZZINESS (dizziness), HEADACHE (mild headache), FATIGUE (fatigue) and CHILLS (chills) had resolved.            Patient advised all AEs have resolved and has nothing further to report  No concomitant medications was reported by the reporter No treatment medications was  provided by the reporter
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Endoscopy, Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRINE), SPIRONOLACTONE, LISINOPRIL, TICAGRELOR (BRILINTA), ATORVASTATIN and METOPROLOL SUCCINATE for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with NITROGLYCERIN at a dose of UNK dosage form and MAGNESIUM OXIDE HEAVY, SODIUM BICARBONATE (ANTACID C) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: abnormal (abnormal) ELECTROCARDIOGRAM DONE FOR THE HEART ATTACK. On an unknown date, Endoscopy: unknown (Inconclusive) unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment drug information was not given.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Magnetic resonance imaging, Nerve stimulation test, Vaccination site pain
Clinical narrative: Injection felt like a "knife going into arm"; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Injection felt like a "knife going into arm") and FATIGUE (Fatigue) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection felt like a "knife going into arm") and FATIGUE (Fatigue). The patient was treated with VITAMIN B12 NOS for Fatigue, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (Injection felt like a "knife going into arm") had not resolved and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, Magnetic resonance imaging: normal (normal) Normal. In June 2021, Nerve stimulation test: normal (normal) Normal.         Concomitant medications information was not provided.  Reportedly, the vaccination site pain turned into more of a "tooth ache" pain that has not gone away.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Headache fever muscle aches
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Injection site reaction, Menstruation irregular, Rash
Clinical narrative: 1. Large red, swollen, itchy, and painful rash on the top part of my left arm.  Started around day 4 after shot and lasted a couple weeks. Pain lasted longer than the rash.   2. Period cycle has been irregular with Longer, more painful cramping and heavier bleeding.  Period cycles have been regular my whole life until after the moderna vaccine. Now 3 cycles later and still irregular, longer, painful and heavier bleeding.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: 1. Large red, swollen, itchy, and painful rash on the top part of my left arm.  Started around day 4 after shot and lasted a couple weeks. Pain lasted longer than the rash.   2. Period cycle has been irregular with Longer, more painful cramping and heavier bleeding.  Period cycles have been regular my whole life until after the moderna vaccine. Now 3 cycles later and still irregular, longer, painful and heavier bleeding.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Thirst
Clinical narrative: very thirsty; couldn't get up from bed; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (very thirsty) and FATIGUE (couldn't get up from bed) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced THIRST (very thirsty) and FATIGUE (couldn't get up from bed). At the time of the report, THIRST (very thirsty) and FATIGUE (couldn't get up from bed) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant medication was not provided.  Treatment medication was not provided.   This case was linked to MOD-2021-114394 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Dizziness, Electrocardiogram, Electroencephalogram
Clinical narrative: 1 week (8/16/21) after vaccine had onset of dizziness causing a fall. On 8/19/21 had another fall hitting head and had to go to the ER.  Hospitalized for 1 night with numerous testing.  Continues to be dizzy -walking with walker along with assistance.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Gait disturbance, Head injury, SARS-CoV-2 test negative, Scan with contrast
Clinical narrative: 1 week (8/16/21) after vaccine had onset of dizziness causing a fall. On 8/19/21 had another fall hitting head and had to go to the ER.  Hospitalized for 1 night with numerous testing.  Continues to be dizzy -walking with walker along with assistance.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Walking aid user
Clinical narrative: 1 week (8/16/21) after vaccine had onset of dizziness causing a fall. On 8/19/21 had another fall hitting head and had to go to the ER.  Hospitalized for 1 night with numerous testing.  Continues to be dizzy -walking with walker along with assistance.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Sudden death
Clinical narrative: Sudden death
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Product storage error
Clinical narrative: A vial of Moderna was opened 30 days prior to administration of the vaccine on the date of 8 August 2021.    The vaccination was given outside  the 12-hour use limit on punctured vials per the manufactures recommendations.   Moderna was contacted and the clinic has been informed that the members that received the vaccination is considered vaccinated since the members had the usual reactions to the vaccination.    There was no additional testing or treatment provided.  This is being reported since there was an error in the administration process.  There were no adverse reactions.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: A vial of Moderna was opened 30 days prior to administration of the vaccine on the date of 8 August 2021.    The vaccination was given outside the 12-hour use limit on punctured vials per the manufactures recommendations.   Moderna was contacted and the clinic has been informed that the members that received the vaccination is considered vaccinated since the members had the usual reactions to the vaccination.    There was no additional testing or treatment provided.  This is being reported since there was an error in the administration process.  There were no adverse reactions.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: A vial of Moderna was opened 30 days prior to administration of the vaccine on the date of 8 August 2021.    The vaccination was given outside the 12-hour use limit on punctured vials per the manufactures recommendations.   Moderna was contacted and the clinic has been informed that the members that received the vaccination is considered vaccinated since the members had the usual reactions to the vaccination.    There was no additional testing or treatment provided.  This is being reported since there was an error in the administration process.  There were no adverse reactions.
Sex: U
Vaccine: COVID19
Symptoms: Tooth disorder
Clinical narrative: dental work done that involves a local anthesia after the first dose of moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TOOTH DISORDER (dental work done that involves a local anthesia after the first dose of moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH DISORDER (dental work done that involves a local anthesia after the first dose of moderna vaccine). At the time of the report, TOOTH DISORDER (dental work done that involves a local anthesia after the first dose of moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, Product administration error
Clinical narrative: Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine; Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On 07-Jun-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine). On 07-Jun-2021, PRODUCT ADMINISTRATION ERROR (Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Received 1st dose from Moderna and 2nd  dose from Pfizer vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received the second shot in the right arm on 07-Jun-2021 and its Pfizer vaccine. Patient reported no adverse events after taking both the doses of vaccine(1st dose Moderna and 2nd dose Pfizer) Patient provided the lot number for the second dose as EW0179 and the expiration date as 31-Aug-2021.  No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Dose administered after improper storage and handling; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PRODUCT STORAGE ERROR (Dose administered after improper storage and handling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jun-2021, the patient experienced PRODUCT STORAGE ERROR (Dose administered after improper storage and handling). On 07-Jun-2021, PRODUCT STORAGE ERROR (Dose administered after improper storage and handling) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment information was reported.  Vaccine was given to 9 patients on 6 JUNE 2021 & 7 JUNE 2021 which were mixed up in the refrigerator, health care professional comes to know that he vaccinated vial was in the refrigerator from 31 to 34 days, but the exact days were not clear to the health care professional.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: it has been 6 or 7 weeks since received first dose (>35 days); This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (it has been 6 or 7 weeks since received first dose (>35 days)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (it has been 6 or 7 weeks since received first dose (>35 days)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (it has been 6 or 7 weeks since received first dose (>35 days)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 31-Jul-2021: Follow-up information included no new information On 02-Aug-2021: Follow-up information included no new information
Sex: U
Vaccine: COVID19
Symptoms: Infection
Clinical narrative: infection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFECTION (infection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFECTION (infection). At the time of the report, INFECTION (infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Cough, Vaccination site oedema
Clinical narrative: Dry cough; Inflamation at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough) and VACCINATION SITE OEDEMA (Inflamation at the site of injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced COUGH (Dry cough) and VACCINATION SITE OEDEMA (Inflamation at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 13-Apr-2021, VACCINATION SITE OEDEMA (Inflamation at the site of injection) had resolved. On 15-Apr-2021, COUGH (Dry cough) had resolved. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Her arm to go sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Her arm to go sore) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Her arm to go sore). At the time of the report, MYALGIA (Her arm to go sore) outcome was unknown.            Concomitant medications and event treatment information, if any, was not provided by the reporter.   This case was linked to MOD-2021-045657 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Toothache
Clinical narrative: This spontaneous case reported by a patient, describes the occurrence of toothache, insomnia (lack of sleep) and fatigue in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included blood pressure management and medications. Concomitant products included penicillin (NOS) from Apr 17, 2021 to an unknown date for toothache. On Mar 22, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 22, 2021, patient experienced insomnia (lack of sleep) and fatigue. On an unknown date, patient experienced toothache. On Mar 23, 2021, insomnia (lack of sleep) and fatigue resolved. At the time of the report, toothache: not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: chills; Fatigue; Headache; Minor patient of age 12 was administered with Moderna vaccine; The patient was administered with Moderna vaccine instead of Pfizer vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Minor patient of age 12 was administered with Moderna vaccine), WRONG PRODUCT ADMINISTERED (The patient was administered with Moderna vaccine instead of Pfizer vaccine), CHILLS (chills), FATIGUE (Fatigue) and HEADACHE (Headache) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.    On 07-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Minor patient of age 12 was administered with Moderna vaccine) and WRONG PRODUCT ADMINISTERED (The patient was administered with Moderna vaccine instead of Pfizer vaccine). On an unknown date, the patient experienced CHILLS (chills), FATIGUE (Fatigue) and HEADACHE (Headache). On 07-Jun-2021, WRONG PRODUCT ADMINISTERED (The patient was administered with Moderna vaccine instead of Pfizer vaccine) had resolved. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Minor patient of age 12 was administered with Moderna vaccine), CHILLS (chills), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Updated contact information of the actual vaccinator. On 06-Jul-2021: Added medical history Seasonal allergies. Added new Events Chills, Fatigue,Headache
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Chronic Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Chronic Fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Chronic Fatigue). At the time of the report, FATIGUE (Chronic Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided.  No Treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant FU- DOB, email address and first dose vaccination date added
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Tiredness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Flare up of arthritis and Blood pressure high. Concomitant products included LOSARTAN for Blood pressure high, MULTIVITAMINS [VITAMINS NOS] for Nutritional supplement, ASCORBIC ACID (VITAMIN C ACID) and ZINC for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced FATIGUE (Tiredness). In March 2021, FATIGUE (Tiredness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included tonic water. Treatment information included antihistamines, Zyrtec 10 mg and ice pack.   This case was linked to MOD-2021-214321, MOD-2021-214321 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Significant follow up received on 15-JUL-2021. Concomitant medications and medical history updated.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Epistaxis
Clinical narrative: Nosebleeds; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nosebleeds) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 13-Apr-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced EPISTAXIS (Nosebleeds). At the time of the report, EPISTAXIS (Nosebleeds) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Blood pressure measurement: high (High) blood pressure has been high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.  It was reported that after the vaccine patient's blood pressure had been high and  experienced nosebleeds every day.  Concomitant medication including arthritis medication (name not provided) was reported. No treatment medication was reported